A national publication on cancer causes, prevention, detection and survivorship will have a Johns Hopkins cancer epidemiologist at the helm for 2019. Elizabeth Platz, M.P.H., Sc.D, is the co-leader for cancer prevention and control at the Johns Hopkins Kimmel Cancer Center. She was named as editor-in-chief of Cancer Epidemiology, Biomarkers & Prevention (CEBP), one of(...)
About Larry Frum
Posts by Larry Frum:
Moving for Melanoma of Delaware Supports Melanoma Research at Johns Hopkins
Members of the Johns Hopkins Melanoma Program participated in an annual 5K walk/run event and received funds raised by the event during a visit in February. The 5K event in Wilmington, Delaware, and sponsored by Moving for Melanoma of Delaware for the past 11 years raises money for melanoma research, community education and support patients and(...)
Pancreatic Cancer Matters: Right Treatment at the Right Time
Our collaborative team of scientists, physicians and allied health workers at the Johns Hopkins Kimmel Cancer Center specialize in translating science learned in the laboratory into exceptional clinical care. The Skip Viragh Center for Pancreas Cancer Clinical Research and Patient Care is a world leader in the diagnosis and management of pancreatic cancer, leading all(...)
The Future of Pancreatic Cancer Treatments
Just eight percent of people with pancreatic cancer live for five years after their diagnosis. Why is this cancer so deadly and where are advances in treatment headed? Elizabeth Jaffee, M.D., deputy director of the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, describes explains in a 2018 interview on WYPR. http://www.wypr.org/post/why-pancreatic-cancer-so-deadly
Immune Checkpoint Inhibitor Therapy Guideline Continues to Draw Readers
A guideline on guide the clinical practice of managing adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy continues to draw readers nearly a year after its publication. The document’s development, led by Julie Brahmer, M.D., co-director of the upper aerodigestive department in the Bloomberg~Kimmel Institute for Cancer Immunotherapy and a professor of(...)
Jaffee looks to the future of checkpoint immunotherapy for cancer treatment
Combinations strategies involving checkpoint immunotherapies were approved as first-line options in two cancer types and showed promise in clinical trials for several hard-to-treat cancers. Important advances were also made with respect to immune-related biomarkers, cellular immunotherapies, and personalized vaccines. Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, is focusing her research(...)
Cancer Patients Who Continue to Inspire – Jonathan Gould
Defying the odds is a familiar theme for Jonathan Gould, a junior on the University of Florida football team. In high school, Gould, from Elkridge, Maryland, met his goal of making his high school football team as the starting punter and kicker. He taught himself how to play the game by watching YouTube videos and(...)
Three Minutes with Oncologist Michael Carducci
Michael Carducci, M.D., is the associate cancer center director for clinical research within the Johns Hopkins Kimmel Cancer Center and the regional research director for the Greater Washington, D.C., area for the Kimmel Cancer Center. In his many years as an oncologist, Carducci has expertise in various types of cancer including bladder, kidney, prostate and(...)
Music Video Features Johns Hopkins Pediatric Oncology Patient to Raise Awareness
A collaboration between a Johns Hopkins pediatric patient, a rising indie alt/pop group and an organization dedicated to spreading the medicine of music created a new music video for an original song, “No Giving Up.” East of Eli, fronted by singer/songwriter/actor Nathan West and his wife and actress Chyler Leigh, joined musical forces with Grammy-winning(...)
Johns Hopkins Kimmel Cancer Center Immunotherapy Experts Named Bloomberg~Kimmel Professors
Three Johns Hopkins Kimmel Cancer Center researchers were recognized as the first Bloomberg~Kimmel professors in cancer immunology during a ceremony at Johns Hopkins. The event marked the beginning of the Bloomberg~Kimmel Professorships program, and the three scientists were recognized for their work in precision immunotherapy, the bacterial contributions in the microbiome, and how targeting the(...)
1 2